SEC Form 3 · accession 0001493152-16-015465
Adhera Therapeutics, Inc. · ATRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Autotelic LLC
10% Owner
Period of report
Nov 15, 2016
Accepted (ET)
Nov 25, 2016 · 3:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000737207
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 23,123,558 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Received in exchange for 2,200,000 shares of the common stock of IthenaPharma Inc. ("Ithena") pursuant to that certain Agreement and Plan of Merger dated as of November 15, 2016 by and among Marina Biotech, Inc., Ithena Acquisition Corporation, Ithena, and Vuong Trieu as the representative of Ithena